ATE442786T1 - Verfahren zur anregung der darmflora - Google Patents
Verfahren zur anregung der darmfloraInfo
- Publication number
- ATE442786T1 ATE442786T1 AT06806443T AT06806443T ATE442786T1 AT E442786 T1 ATE442786 T1 AT E442786T1 AT 06806443 T AT06806443 T AT 06806443T AT 06806443 T AT06806443 T AT 06806443T AT E442786 T1 ATE442786 T1 AT E442786T1
- Authority
- AT
- Austria
- Prior art keywords
- stimulating
- intestinal flora
- flora
- intestinal
- Prior art date
Links
- 230000000968 intestinal effect Effects 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/151—Johnsonii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/157—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/187—Zeae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/521—Catenulatum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/527—Gallicum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/529—Infantis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/535—Pseudocatenulatum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/537—Thermacidophilum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pediatric Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05023029A EP1776877A1 (de) | 2005-10-21 | 2005-10-21 | Methode zur Förderung der Darmflora |
PCT/EP2006/010159 WO2007045502A1 (en) | 2005-10-21 | 2006-10-20 | Method for stimulating the intestinal flora |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE442786T1 true ATE442786T1 (de) | 2009-10-15 |
Family
ID=35809614
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06799537T ATE476877T1 (de) | 2005-10-21 | 2006-10-06 | Vorbeugung von krankheiten bei kaiserschnitt- babies |
AT06799538T ATE432620T1 (de) | 2005-10-21 | 2006-10-06 | Verfahren zur stimulation der darmbarriere- integrität nach unnatürlicher geburt |
AT06799536T ATE440508T1 (de) | 2005-10-21 | 2006-10-06 | Verfahren zur behandlung und/oder vorbeugung von infektionen bei kleinkindern, die über kaiserschnitt geboren werden |
AT06806443T ATE442786T1 (de) | 2005-10-21 | 2006-10-20 | Verfahren zur anregung der darmflora |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06799537T ATE476877T1 (de) | 2005-10-21 | 2006-10-06 | Vorbeugung von krankheiten bei kaiserschnitt- babies |
AT06799538T ATE432620T1 (de) | 2005-10-21 | 2006-10-06 | Verfahren zur stimulation der darmbarriere- integrität nach unnatürlicher geburt |
AT06799536T ATE440508T1 (de) | 2005-10-21 | 2006-10-06 | Verfahren zur behandlung und/oder vorbeugung von infektionen bei kleinkindern, die über kaiserschnitt geboren werden |
Country Status (21)
Country | Link |
---|---|
US (8) | US20090263537A1 (de) |
EP (11) | EP1776877A1 (de) |
JP (1) | JP2009512686A (de) |
CN (9) | CN101360429B (de) |
AR (4) | AR056145A1 (de) |
AT (4) | ATE476877T1 (de) |
AU (3) | AU2006304992A1 (de) |
BR (3) | BRPI0617653C1 (de) |
CA (3) | CA2626636C (de) |
DE (4) | DE602006008817D1 (de) |
DK (7) | DK1940246T3 (de) |
ES (8) | ES2350321T3 (de) |
HU (2) | HUE028348T2 (de) |
MY (4) | MY145999A (de) |
NZ (3) | NZ599302A (de) |
PL (8) | PL1940247T3 (de) |
PT (8) | PT1940245E (de) |
RU (6) | RU2437581C2 (de) |
SG (2) | SG176521A1 (de) |
TR (1) | TR201808654T4 (de) |
WO (4) | WO2007046697A1 (de) |
Families Citing this family (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080126195A1 (en) | 2004-07-22 | 2008-05-29 | Ritter Andrew J | Methods and Compositions for Treating Lactose Intolerance |
EP1776877A1 (de) | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Methode zur Förderung der Darmflora |
ATE509624T1 (de) | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
US20080254166A1 (en) * | 2007-01-25 | 2008-10-16 | Potter Susan M | Food Additives Containing Combinations of Prebiotics and Probiotics |
EP1974743A1 (de) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotika zur Verbesserung der Darm-Biozönose |
WO2008153377A1 (en) * | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
CN101686716B (zh) * | 2007-06-25 | 2013-12-18 | 帝斯曼知识产权资产管理有限公司 | 益生元 |
WO2009039101A1 (en) * | 2007-09-17 | 2009-03-26 | Cornell University | Branched chain fatty acids for prevention or treatment of gastrointestinal disorders |
PL2190304T3 (pl) * | 2007-09-17 | 2012-04-30 | Nutricia Nv | Preparat odżywczy o wysokiej wartości energetycznej |
BRPI0818079B8 (pt) | 2007-10-09 | 2021-07-27 | Enzymotec Ltd | composição de lipídeo |
WO2009067000A1 (en) * | 2007-11-20 | 2009-05-28 | N.V. Nutricia | Composition with synbiotics |
EP2072052A1 (de) * | 2007-12-17 | 2009-06-24 | Nestec S.A. | Verhinderung opportunistischer Infektionen bei Personen mit schwachem Immunsystem |
RU2478309C2 (ru) * | 2007-12-21 | 2013-04-10 | Н.В. Нютрисиа | Применение сфингомиелина и неперевариваемых углеводов для нормализации микробиоты кишечника |
WO2009099316A1 (en) * | 2008-02-08 | 2009-08-13 | N.V. Nutricia | Use of lipid-rich nutrition for the treatment of post-operative ileus |
WO2009102193A1 (en) * | 2008-02-12 | 2009-08-20 | N.V. Nutricia | A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants |
PT2265135T (pt) * | 2008-03-14 | 2018-02-21 | Nestec Sa | Mistura simbiótica |
EP2143341A1 (de) * | 2008-07-08 | 2010-01-13 | Nestec S.A. | Nährstoffzusammensetzung mit Oligosaccharid-Mischung |
US20110098246A1 (en) * | 2008-06-06 | 2011-04-28 | N.V. Nutricia | Method for preventing corticosteroid usage |
EP2130440A1 (de) * | 2008-06-06 | 2009-12-09 | N.V. Nutricia | Hemmen des E. Sakazakii-Wachstums |
WO2009151315A1 (en) * | 2008-06-13 | 2009-12-17 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
AR072141A1 (es) * | 2008-06-13 | 2010-08-11 | Nutricia Nv | Composicion nutricional para lactantes nacidos por cesarea |
WO2010002241A1 (en) * | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
EP2147678A1 (de) * | 2008-07-21 | 2010-01-27 | Nestec S.A. | Probiotika zur Erhöhung der IgA-Sekretion bei per Kaiserschnitt geborenen Kindern |
CA2984935C (en) | 2009-02-24 | 2021-01-12 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
CN101861984B (zh) * | 2009-04-16 | 2012-05-23 | 罗晶 | 低聚糖魔芋米及其制备方法 |
MX338680B (es) * | 2009-05-11 | 2016-04-27 | Nestec Sa | Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes. |
ES2433429T3 (es) | 2009-07-15 | 2013-12-11 | N.V. Nutricia | Mezcla de oligosacáridos no digeribles para estimular el sistema inmunológico |
ES2904608T3 (es) * | 2009-07-15 | 2022-04-05 | Nutricia Nv | Fucosil lactosa como oligosacárido no digerible idéntico al de la leche materna para tratar y/o prevenir la diarrea vírica |
CN102481009A (zh) * | 2009-08-13 | 2012-05-30 | 雀巢产品技术援助有限公司 | 包含外源性核苷酸的营养组合物 |
FR2955774A1 (fr) * | 2010-02-02 | 2011-08-05 | Aragan | Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation |
IT1398553B1 (it) * | 2010-03-08 | 2013-03-01 | Probiotical Spa | Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario. |
WO2011139621A1 (en) * | 2010-04-26 | 2011-11-10 | Nestec S.A. | Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition |
EP3202406A1 (de) | 2010-04-28 | 2017-08-09 | Ritter Pharmaceuticals, Inc. | Präbiotische formulierungen und deren verwendungen |
EP3097791B1 (de) * | 2010-06-04 | 2018-05-16 | N.V. Nutricia | Unverdauliche oligosachharide für die orale induktion von verträglichkeit gegenüber milchproteinen |
WO2011150949A1 (en) | 2010-06-04 | 2011-12-08 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
WO2012009315A2 (en) | 2010-07-12 | 2012-01-19 | The Regents Of The University Of California | Bovine milk oligosaccharides |
US9011909B2 (en) | 2010-09-03 | 2015-04-21 | Wisconsin Pharmacal Company, Llc | Prebiotic suppositories |
WO2012044155A1 (en) | 2010-09-28 | 2012-04-05 | N.V. Nutricia | Fat composition for programming immune response |
EP2454948A1 (de) * | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharidmischung und Lebensmittel mit dieser Mischung, insbesondere Säuglingsnahrung |
CN107890097A (zh) * | 2010-12-06 | 2018-04-10 | N·V·努特里奇亚 | 发酵的婴儿配方物 |
ES2875458T3 (es) | 2010-12-29 | 2021-11-10 | Abbott Lab | Producto nutricional para uso en la reducción de la incidencia de enterocolitis necrosante en un lactante, niño pequeño o niño |
MY171620A (en) | 2010-12-31 | 2019-10-21 | Abbott Lab | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides |
SG10201707519PA (en) | 2010-12-31 | 2017-10-30 | Abbott Lab | Neutral human milk oligosaccharides to promote growth of beneficial bacteria |
CN103501638A (zh) | 2010-12-31 | 2014-01-08 | 雅培制药有限公司 | 包含人乳低聚糖和核苷酸的营养型组合物以及其治疗和/或预防肠病毒感染的用途 |
US9283240B2 (en) | 2010-12-31 | 2016-03-15 | Abbott Laboratories | Human milk oligosaccharides for modulating inflammation |
MX338174B (es) | 2010-12-31 | 2016-04-06 | Abbott Lab | Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios. |
CA2822495C (en) | 2010-12-31 | 2020-12-22 | Abbott Laboratories | Methods of using human milk oligosaccharides for improving airway respiratory health |
MY166945A (en) | 2010-12-31 | 2018-07-25 | Abbott Lab | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof |
CN103763940B (zh) * | 2010-12-31 | 2015-10-14 | 雅培制药有限公司 | 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合 |
WO2012138698A1 (en) * | 2011-04-08 | 2012-10-11 | Ancora Pharmaceuticals Inc. | Synthesis of beta-mannuronic acid oligosaccharides |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
MX368124B (es) | 2011-08-29 | 2019-09-19 | Abbott Lab | Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal. |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
EP2836224A4 (de) | 2012-02-29 | 2015-12-16 | Ethicon Endo Surgery Inc | Zusammensetzungen von biozönose und zugehörige verfahren |
WO2013187755A1 (en) | 2012-06-14 | 2013-12-19 | N.V. Nutricia | Fermented infant formula with non digestible oligosaccharides |
PL2914136T3 (pl) * | 2012-11-02 | 2021-11-29 | N.V. Nutricia | Połączenie synbiotyków do poprawy czynności mózgu |
CN103193896B (zh) * | 2013-03-12 | 2015-09-16 | 武汉纤浓生物科技有限公司 | 一种魔芋葡甘低聚糖的制备方法及其所采用的薄膜蒸发器 |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
US20160074422A1 (en) * | 2013-05-08 | 2016-03-17 | Northeastern University | Mucus strengthening formulations to alter mucus barrier properties |
ES2912278T3 (es) | 2013-11-15 | 2022-05-25 | Nestle Sa | Composiciones para su uso en la prevención o el tratamiento de la enterocolitis necrosante en lactantes o niños pequeños nacidos por cesárea |
WO2015071389A1 (en) | 2013-11-15 | 2015-05-21 | Nestec S.A. | Compositions for use in the prevention or treatment of urt infections in infants or young children at risk |
MX2016006060A (es) * | 2013-11-15 | 2016-08-03 | Nestec Sa | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños. |
WO2015079016A1 (en) * | 2013-11-29 | 2015-06-04 | Galderma Sa | Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis |
EP3182841A1 (de) * | 2014-08-18 | 2017-06-28 | Nestec S.A. | Präbiotika zur verringerung des risikos von adipositas im späteren leben |
WO2016050752A1 (en) * | 2014-09-30 | 2016-04-07 | Nestec S.A. | Nutritional composition for use in promoting gut and/or liver maturation and/or repair |
DK3209308T3 (da) * | 2014-10-24 | 2022-10-03 | Evolve Biosystems Inc | Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf |
GB2551642B (en) | 2014-10-31 | 2020-09-23 | Pendulum Therapeutics Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
CZ306548B6 (cs) * | 2014-12-04 | 2017-03-01 | Výzkumný ústav mlékárenský, s.r.o. | Probiotický přípravek sušený se zvlhčujícím efektem pro speciální aplikace |
SI3193901T1 (en) | 2014-12-23 | 2018-06-29 | 4D Pharma Research Limited | Pirin polypeptide and immune modulation |
NO3065748T3 (de) | 2014-12-23 | 2018-04-21 | ||
RU2020107846A (ru) * | 2015-03-05 | 2020-03-16 | Сосьете Де Продюи Нестле С.А. | Композиции для применения в профилактике или лечении отита или бронхита у младенцев или детей младшего возраста |
MX2017011669A (es) * | 2015-03-13 | 2017-11-06 | Evolve Biosystems Inc | Composiciones que metabolizan o secuestran monomeros libres de azucar y usos de las mismas. |
DK3294073T3 (da) | 2015-05-11 | 2022-11-14 | Mybiotics Pharma Ltd | Systemer og fremgangsmåder til dyrkning af en biofilm af probiotiske bakterier på faste partikler til kolonisering af bakterier i tarmen |
WO2016183535A1 (en) * | 2015-05-14 | 2016-11-17 | University Of Puerto Rico | Methods for restoring microbiota of newborns |
KR101589466B1 (ko) * | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | 성장 촉진을 위한 비피도박테리움 롱굼 cbt bg7 균주 및 이를 포함하는 성장촉진용 기능성 식품 조성물 |
KR101589465B1 (ko) * | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | 성장 촉진을 위한 비피도박테리움 브레베 cbt br3 균주 및 이를 포함하는 성장촉진용 기능성 식품 조성물 |
CN106259952B (zh) * | 2015-06-01 | 2019-01-15 | 内蒙古伊利实业集团股份有限公司 | 含有核苷酸和膳食纤维的1-3岁幼儿配方奶粉及其制备方法 |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
HUE044617T2 (hu) | 2015-06-15 | 2019-11-28 | 4D Pharma Res Ltd | Baktériumtörzseket tartalmazó készítmények |
ME03563B (de) | 2015-06-15 | 2020-07-20 | 4D Pharma Res Ltd | Zusammensetzungen mit bakterienstämmen |
SG10201912324XA (en) | 2015-06-15 | 2020-02-27 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
RU2721257C2 (ru) * | 2015-06-23 | 2020-05-18 | Сосьете Де Продюи Нестле С.А. | Питательные композиции и детские смеси, содержащие олигофруктозу, для снижения нагрузки патогенных бактерий в кишечнике младенцев и детей младшего возраста |
WO2017043962A1 (en) * | 2015-09-11 | 2017-03-16 | N.V. Nutricia | Method for stimulating microbiota health after non-natural birth |
WO2017043963A1 (en) | 2015-09-11 | 2017-03-16 | N.V. Nutricia | Kit of parts for stimulating microbiota health after non-natural birth |
CN105176822B (zh) * | 2015-10-23 | 2019-01-11 | 广州康泽医疗科技有限公司 | 一种人类肠道益生菌的优化分离方法 |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
MD3209310T2 (ro) | 2015-11-20 | 2018-06-30 | 4D Pharma Res Ltd | Compoziții care conțin tulpini bacteriene |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
WO2017117142A1 (en) | 2015-12-28 | 2017-07-06 | New York University | Device and method of restoring microbiota of newborns |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
CN114712405A (zh) | 2016-03-04 | 2022-07-08 | 4D制药有限公司 | 包含细菌菌株的组合物 |
CN109069549A (zh) * | 2016-03-11 | 2018-12-21 | 进化生物系统股份有限公司 | 用于断奶的食物组合物 |
JP7198087B2 (ja) | 2016-05-25 | 2022-12-28 | マイバイオティクス ファーマ リミテッド | 微生物叢療法のための組成物及び方法 |
AU2017290900A1 (en) | 2016-07-01 | 2019-01-17 | Infinant Health, Inc | Method for facilitating maturation of the mammalian immune system |
TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
ES2858799T3 (es) * | 2016-09-13 | 2021-09-30 | Nestle Sa | Composición nutricional fermentada para sujetos alérgicos a las proteínas de leche de vaca |
CN106267383A (zh) * | 2016-09-22 | 2017-01-04 | 南昌大学 | 一种用于恢复剖腹产新生儿共生微生物抹布的制备方法 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
CN110573164B (zh) * | 2017-03-08 | 2023-09-29 | N·V·努特里奇亚 | 用于减轻鼻上皮炎症的含有不可消化的低聚糖的组合物 |
EP3630137B1 (de) | 2017-05-22 | 2023-05-17 | 4D Pharma Research Limited | Zusammensetzungen mit bakterienstämmen |
MA41708A (fr) | 2017-05-24 | 2020-04-08 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
PL3600364T3 (pl) | 2017-06-14 | 2021-01-11 | 4D Pharma Research Limited | Kompozycje zawierające szczep bakteryjny z rodzaju megasphaera i ich zastosowania |
SI3638271T1 (sl) | 2017-06-14 | 2021-01-29 | 4D Pharma Research Limited | Sestavki, ki vsebujejo bakterijske seve |
WO2019031961A1 (en) | 2017-08-11 | 2019-02-14 | N.V. Nutricia | OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION |
WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
WO2019115382A1 (en) | 2017-12-11 | 2019-06-20 | N.V. Nutricia | Composition for use for treating delayed colonization by bifidobacterium after birth |
CN111935995A (zh) * | 2018-03-29 | 2020-11-13 | 森永乳业株式会社 | 营养组合物以及使用了该营养组合物的饮食品组合物和配方奶粉 |
WO2019246316A1 (en) * | 2018-06-19 | 2019-12-26 | Evolve Biosystems, Inc. | Novel oligosaccharides for use in prebiotic applications |
RU2729633C2 (ru) * | 2018-07-05 | 2020-08-11 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Биологически активная пищевая добавка для профилактики воспалительного заболевания кишечника и функциональных кишечных расстройств и способ ее получения |
US10709744B1 (en) | 2019-03-28 | 2020-07-14 | Mybiotics Pharma Ltd. | Probiotic biofilm suppositories |
JP2022535323A (ja) * | 2019-03-28 | 2022-08-08 | マイバイオティクス ファーマ リミテッド | プロバイオティクスバイオフィルム組成物およびそれを調製する方法 |
CN110882264B (zh) * | 2019-11-13 | 2021-03-26 | 青岛海洋生物医药研究院股份有限公司 | 一种天麻素和甘露糖醛酸寡糖的药物组合物及其用途 |
EP4129302A4 (de) * | 2020-04-03 | 2024-04-17 | Inner Mongolia Yili Ind Group | Muttermilcholigosaccharide zur verbesserung der resistenz eines organismus gegen staphylococcus-aureus-infektionen |
CN112933104B (zh) * | 2021-02-02 | 2021-12-14 | 陈玉松 | 核苷酸的新用途 |
WO2023118510A1 (en) | 2021-12-22 | 2023-06-29 | N.V. Nutricia | Mix of specific bifidobacterium species and specific non-digestible oligosaccharides |
WO2023216181A1 (en) | 2022-05-12 | 2023-11-16 | N.V. Nutricia | Improving micriobiota of infants born by caesarean section |
EP4299066A1 (de) * | 2022-06-27 | 2024-01-03 | Hipp & Co | Neuer bifidobacterium breve-stamm |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2007350A6 (es) * | 1987-05-29 | 1989-06-16 | Ganadera Union Ind Agro | Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion. |
SU1743607A1 (ru) * | 1990-02-05 | 1992-06-30 | 2-й Московский государственный медицинский институт им.Н.И.Пирогова | Способ профилактики дисбактериоза кишечника у новорожденных детей |
US5472952A (en) * | 1993-03-18 | 1995-12-05 | Bristol-Myers Squibb Company | Partially hydrolyzed pectin in nutritional compositions |
IT1288119B1 (it) | 1996-06-28 | 1998-09-10 | Renata Maria Anna Ve Cavaliere | Composizioni dietetiche da utilizzare nell'alimentazione per via enterica |
NZ334021A (en) | 1996-08-09 | 2001-01-26 | Mannatech Inc | Dietary supplement containing at least two saccharides being the building blocks of glycoproteins |
EP0856259B1 (de) * | 1996-12-23 | 1998-08-12 | SITIA-YOMO S.p.A. | Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung |
CN1099289C (zh) * | 1997-08-01 | 2003-01-22 | 北京东方百信生物技术有限公司 | 改善肠道生态平衡的微生物制剂及其工艺 |
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
FR2782257B1 (fr) | 1998-08-13 | 2000-11-17 | Seb Sa | Joint indexe pour autocuiseur, et autocuiseur equipe d'un tel joint |
NL1010770C2 (nl) | 1998-12-09 | 2000-06-13 | Nutricia Nv | Preparaat dat oligosacchariden en probiotica bevat. |
JP3149403B2 (ja) * | 1999-03-02 | 2001-03-26 | 明治乳業株式会社 | ビフィズス菌によるオリゴ糖利用能改善剤 |
FR2795917B1 (fr) | 1999-07-06 | 2001-08-31 | Gervais Danone Sa | Procede de preparation d'un produit lacte immunostimulant et ses applications |
DE19958985A1 (de) * | 1999-12-07 | 2001-06-13 | Nutricia Nv | Oligosaccharidmischung |
US6613549B2 (en) * | 2000-02-10 | 2003-09-02 | Urex Biotech, Inc. | Probiotic therapy for newborns |
DE10006989A1 (de) * | 2000-02-16 | 2001-08-23 | Nutricia Nv | Antiadhäsive Kohlenhydratmischung |
US20040143013A1 (en) * | 2000-02-28 | 2004-07-22 | Bristol-Myers Squibb Company | Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants |
US6495599B2 (en) | 2000-04-13 | 2002-12-17 | Abbott Laboratories | Infant formulas containing long-chain polyunsaturated fatty acids and uses therof |
DE10057976B4 (de) * | 2000-11-22 | 2005-02-03 | Südzucker AG Mannheim/Ochsenfurt | Verfahren zur Herstellung von Pektinhydrolyseprodukten |
US6511696B2 (en) * | 2000-12-13 | 2003-01-28 | Novartis Nutrition Ag | Infant formula with free amino acids and nucleotides |
EP1355542B2 (de) * | 2000-12-27 | 2012-04-04 | N.V. Nutricia | Ernährungszusammensetzung mit gesundheitsfördernder wirkung enthaltend oligosaccharide |
FI109602B (fi) * | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
US7223434B2 (en) | 2001-11-21 | 2007-05-29 | Gerber Products Company | Blended baby foods |
EP1364586A1 (de) | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotika und Oraltoleranz |
ATE419759T1 (de) | 2002-10-10 | 2009-01-15 | Wyeth Corp | Nukleotidhaltige fertig-babynahrung |
WO2004032639A1 (en) * | 2002-10-11 | 2004-04-22 | Wyeth | Nutritional formulations containing synbiotic substances |
WO2004067013A1 (en) * | 2003-01-24 | 2004-08-12 | Flora Technology Inc. | Compositions and methods for restoring bacterial flora |
AU2003303894A1 (en) | 2003-01-30 | 2004-08-30 | The Regents Of The University Of California | Inactivated probiotic bacteria and methods of use thereof |
US20050175759A1 (en) * | 2004-02-09 | 2005-08-11 | Atul Singhal | Newborn infant formulas and feeding methods |
FR2853908B1 (fr) | 2003-04-16 | 2005-06-03 | Gervais Danone Sa | Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant |
US8394370B2 (en) * | 2003-06-23 | 2013-03-12 | Nestec S.A. | Nutritional formula for optimal gut barrier function |
PL1638414T3 (pl) | 2003-06-23 | 2009-12-31 | Nestec Sa | Mleko modyfikowane niemowlęce lub następne |
CN1566329A (zh) * | 2003-07-09 | 2005-01-19 | 喻超 | 一种延长5种双歧杆菌固体发酵物活菌保存期的制剂 |
WO2005051088A2 (en) * | 2003-11-12 | 2005-06-09 | Abbott Laboratories | Iron-containing human milk fortifier with improved antimicrobial properties |
EP1675480B1 (de) | 2003-10-16 | 2018-06-13 | Nestec S.A. | Nahrhafte zusammensetzung gegen die nebenwirkungen von chemotherapie oder strahlentherapie |
EP2033529B1 (de) | 2003-10-24 | 2019-12-11 | N.V. Nutricia | Synbiotische Zusammensetzung für Kleinkinder |
EP2123282A3 (de) * | 2003-10-24 | 2010-01-20 | N.V. Nutricia | Immunmodulierende Oligosaccharide |
CN1305383C (zh) * | 2003-11-03 | 2007-03-21 | 东北农业大学 | 一种含有双歧杆菌冻干粉的奶粉制品及其制备方法 |
EP1597978A1 (de) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergie von GOS und polyfruktose |
US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
EP1634599A1 (de) | 2004-08-20 | 2006-03-15 | N.V. Nutricia | Immunstimulierende Kindernahrung |
PT1629850E (pt) * | 2004-08-24 | 2007-08-14 | Nutricia Nv | Composição nutricional que compreende a administração de oligossacarídeos indigeríveis |
ES2781328T3 (es) * | 2005-02-21 | 2020-09-01 | Nestle Sa | Mezcla de oligosacáridos |
PL2805625T5 (pl) | 2005-02-28 | 2023-03-13 | N.V. Nutricia | Kompozycja odżywcza z prebiotykami i probiotykami |
BRPI0608782A2 (pt) | 2005-04-13 | 2010-01-26 | Nestec Sa | fórmula para bebê com probióticos |
US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
EP1714660A1 (de) * | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Uronsäure und Probiotika |
DK2258219T4 (da) | 2005-04-27 | 2022-08-29 | Nutricia Nv | Næring med lipider og ikke-fordøjelige saccharider |
EP1776877A1 (de) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Methode zur Förderung der Darmflora |
WO2010002241A1 (en) * | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
-
2005
- 2005-10-21 EP EP05023029A patent/EP1776877A1/de not_active Withdrawn
-
2006
- 2006-10-06 EP EP06799536A patent/EP1940245B1/de not_active Not-in-force
- 2006-10-06 DE DE602006008817T patent/DE602006008817D1/de active Active
- 2006-10-06 WO PCT/NL2006/050246 patent/WO2007046697A1/en active Application Filing
- 2006-10-06 AT AT06799537T patent/ATE476877T1/de active
- 2006-10-06 CN CN200680047835.6A patent/CN101360429B/zh not_active Expired - Fee Related
- 2006-10-06 ES ES06799537T patent/ES2350321T3/es active Active
- 2006-10-06 JP JP2008536530A patent/JP2009512686A/ja active Pending
- 2006-10-06 CN CN201210414761.2A patent/CN102919663B/zh active Active
- 2006-10-06 BR BRPI0617653A patent/BRPI0617653C1/pt not_active IP Right Cessation
- 2006-10-06 PT PT06799536T patent/PT1940245E/pt unknown
- 2006-10-06 HU HUE11178047A patent/HUE028348T2/en unknown
- 2006-10-06 US US12/091,047 patent/US20090263537A1/en not_active Abandoned
- 2006-10-06 DK DK06799537.3T patent/DK1940246T3/da active
- 2006-10-06 AT AT06799538T patent/ATE432620T1/de active
- 2006-10-06 CN CNA2006800473329A patent/CN101330837A/zh active Pending
- 2006-10-06 AU AU2006304992A patent/AU2006304992A1/en not_active Abandoned
- 2006-10-06 PL PL06799538T patent/PL1940247T3/pl unknown
- 2006-10-06 RU RU2008120024/13A patent/RU2437581C2/ru not_active IP Right Cessation
- 2006-10-06 CA CA2626636A patent/CA2626636C/en not_active Expired - Fee Related
- 2006-10-06 CA CA2626615A patent/CA2626615C/en active Active
- 2006-10-06 AU AU2006304993A patent/AU2006304993A1/en not_active Abandoned
- 2006-10-06 MY MYPI20081206A patent/MY145999A/en unknown
- 2006-10-06 DK DK06799538T patent/DK1940247T3/da active
- 2006-10-06 ES ES11178047.4T patent/ES2560291T3/es active Active
- 2006-10-06 PT PT91616748T patent/PT2105055E/pt unknown
- 2006-10-06 ES ES06799538T patent/ES2327781T3/es active Active
- 2006-10-06 ES ES09161674.8T patent/ES2460590T3/es active Active
- 2006-10-06 EP EP06799538A patent/EP1940247B1/de not_active Revoked
- 2006-10-06 NZ NZ599302A patent/NZ599302A/xx unknown
- 2006-10-06 NZ NZ616421A patent/NZ616421A/en unknown
- 2006-10-06 DE DE602006016150T patent/DE602006016150D1/de active Active
- 2006-10-06 CN CN200680047651XA patent/CN101330838B/zh active Active
- 2006-10-06 EP EP11178047.4A patent/EP2407036B1/de not_active Revoked
- 2006-10-06 WO PCT/NL2006/050247 patent/WO2007046698A1/en active Application Filing
- 2006-10-06 SG SG2011087186A patent/SG176521A1/en unknown
- 2006-10-06 SG SG10201503970XA patent/SG10201503970XA/en unknown
- 2006-10-06 NZ NZ567579A patent/NZ567579A/en unknown
- 2006-10-06 MY MYPI20081205A patent/MY146454A/en unknown
- 2006-10-06 BR BRPI0617645-3A patent/BRPI0617645A2/pt not_active Application Discontinuation
- 2006-10-06 DK DK11178047.4T patent/DK2407036T3/en active
- 2006-10-06 PL PL11178047T patent/PL2407036T3/pl unknown
- 2006-10-06 EP EP06799537A patent/EP1940246B1/de not_active Revoked
- 2006-10-06 DK DK09161674.8T patent/DK2105055T3/da active
- 2006-10-06 AT AT06799536T patent/ATE440508T1/de not_active IP Right Cessation
- 2006-10-06 RU RU2008119992/13A patent/RU2424736C2/ru active
- 2006-10-06 EP EP09161674.8A patent/EP2105055B1/de not_active Revoked
- 2006-10-06 US US12/091,050 patent/US20090221486A1/en not_active Abandoned
- 2006-10-06 PT PT06799538T patent/PT1940247E/pt unknown
- 2006-10-06 DE DE602006007161T patent/DE602006007161D1/de active Active
- 2006-10-06 WO PCT/NL2006/050248 patent/WO2007046699A2/en active Application Filing
- 2006-10-06 PT PT06799537T patent/PT1940246E/pt unknown
- 2006-10-06 EP EP15181073.6A patent/EP2984943A1/de not_active Withdrawn
- 2006-10-06 PT PT111780474T patent/PT2407036E/pt unknown
- 2006-10-06 PL PL06799537T patent/PL1940246T3/pl unknown
- 2006-10-06 PL PL09161674T patent/PL2105055T3/pl unknown
- 2006-10-06 CN CN201310722592.3A patent/CN103816173B/zh active Active
- 2006-10-06 US US12/091,011 patent/US8715769B2/en active Active
- 2006-10-20 CA CA2620821A patent/CA2620821C/en active Active
- 2006-10-20 AT AT06806443T patent/ATE442786T1/de active
- 2006-10-20 AR ARP060104593A patent/AR056145A1/es unknown
- 2006-10-20 CN CN201510171216.9A patent/CN105124565A/zh active Pending
- 2006-10-20 PT PT06806443T patent/PT1940250E/pt unknown
- 2006-10-20 CN CNA2006800354743A patent/CN101272701A/zh active Pending
- 2006-10-20 DE DE602006009287T patent/DE602006009287D1/de active Active
- 2006-10-20 EP EP13171226.7A patent/EP2638812B1/de active Active
- 2006-10-20 EP EP06806443A patent/EP1940250B1/de not_active Revoked
- 2006-10-20 TR TR2018/08654T patent/TR201808654T4/tr unknown
- 2006-10-20 PL PL06806443T patent/PL1940250T3/pl unknown
- 2006-10-20 PL PL09011197T patent/PL2140771T3/pl unknown
- 2006-10-20 PL PL17205437T patent/PL3326634T3/pl unknown
- 2006-10-20 EP EP17205437.1A patent/EP3326634B1/de active Active
- 2006-10-20 EP EP09011197.2A patent/EP2140771B1/de not_active Revoked
- 2006-10-20 BR BRPI0617507-4A patent/BRPI0617507A2/pt not_active Application Discontinuation
- 2006-10-20 HU HUE13171226A patent/HUE037858T2/hu unknown
- 2006-10-20 MY MYPI20081180A patent/MY145311A/en unknown
- 2006-10-20 PT PT90111972T patent/PT2140771E/pt unknown
- 2006-10-20 AR ARP060104605A patent/AR058132A1/es unknown
- 2006-10-20 US US12/083,612 patent/US20090162323A1/en not_active Abandoned
- 2006-10-20 AR ARP060104611A patent/AR058136A1/es unknown
- 2006-10-20 DK DK09011197.2T patent/DK2140771T3/en active
- 2006-10-20 ES ES17205437T patent/ES2857732T3/es active Active
- 2006-10-20 ES ES09011197.2T patent/ES2451020T3/es active Active
- 2006-10-20 PL PL13171226T patent/PL2638812T3/pl unknown
- 2006-10-20 CN CN201510170125.3A patent/CN104814442A/zh active Pending
- 2006-10-20 PT PT131712267T patent/PT2638812T/pt unknown
- 2006-10-20 AU AU2006303477A patent/AU2006303477A1/en not_active Abandoned
- 2006-10-20 ES ES06806443T patent/ES2332064T3/es active Active
- 2006-10-20 CN CN201310148476.5A patent/CN103230005B/zh active Active
- 2006-10-20 DK DK13171226.7T patent/DK2638812T3/en active
- 2006-10-20 RU RU2008115436/15A patent/RU2497535C2/ru active
- 2006-10-20 ES ES13171226.7T patent/ES2671914T3/es active Active
- 2006-10-20 WO PCT/EP2006/010159 patent/WO2007045502A1/en active Application Filing
- 2006-10-20 AR ARP060104606A patent/AR058133A1/es not_active Application Discontinuation
- 2006-10-20 DK DK06806443T patent/DK1940250T3/da active
-
2008
- 2008-04-18 MY MYPI2012001490A patent/MY169058A/en unknown
-
2011
- 2011-09-08 RU RU2011137129/15A patent/RU2011137129A/ru unknown
-
2013
- 2013-05-29 RU RU2013125030A patent/RU2639490C2/ru active
- 2013-12-19 US US14/135,171 patent/US9107438B2/en active Active
-
2015
- 2015-07-30 US US14/813,845 patent/US9585416B2/en active Active
- 2015-09-04 US US14/846,120 patent/US20160058806A1/en not_active Abandoned
- 2015-12-17 US US14/973,166 patent/US9596876B2/en active Active
-
2017
- 2017-12-06 RU RU2017142555A patent/RU2762984C2/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE442786T1 (de) | Verfahren zur anregung der darmflora | |
DE602005024119D1 (de) | Verfahren zum allergennachweis | |
ATE408604T1 (de) | Verfahren zur herstellung von 1-alkyl-3- phenyluracilen | |
ATE455105T1 (de) | Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten | |
DE602006020386D1 (de) | Duraimplantat und Verfahren zu seiner Herstellung | |
DE502007002301D1 (de) | Verfahren zum Herstellen von Ventilgehäusen | |
ZA200711186B (en) | Crosslinking method | |
DE502005010287D1 (de) | Verfahren zur hydrocyanierung | |
DE602006007648D1 (de) | Verfahren zur implementierung der zugriffsbereichs | |
ATE480531T1 (de) | Verfahren zur herstellung von benzopyran-2- olderivaten | |
DE602006020089D1 (de) | Verfahren zur CVI | |
DE502006009351D1 (de) | Feinteiliges azopigment und verfahren zu seiner herstellung | |
ATE444303T1 (de) | Verfahren zur herstellung von ferrisuccinylcasein | |
ATE523483T1 (de) | Verfahren zur herstellung von betainen | |
DE602006014866D1 (de) | Elastisches polyurethangarn und verfahren zu seiner herstellung | |
DE502006006353D1 (de) | Verfahren zur hydrosilylierung | |
DE112007002936B8 (de) | Plattierelement und Verfahren zum Herstellen desselben | |
ATE438613T1 (de) | Verfahren zur herstellung von anilinen | |
DK1955066T3 (da) | Membran-assay-fremgangsmåde | |
DE112006002397A5 (de) | Verfahren zur Farbzahlverbesserung | |
ATE437638T1 (de) | Verfahren zur bekämpfung von infektionen | |
DE112005000765A5 (de) | Verfahren zur Lösung der Navier-STOKES-Gleichung | |
DE502006008620D1 (de) | Verbessertes verfahren zur gewinnung von betulinsäure | |
GB0525656D0 (en) | Diagnostic method | |
DE502004012400D1 (de) | Verfahren zur Verstellung der Ventilöffnungsdauer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1940250 Country of ref document: EP |